The Insulin Glargine Market represents a critical segment within the global diabetes therapeutics landscape, driven by the growing prevalence of diabetes and the increasing demand for long-acting insulin analogs. Insulin glargine is widely prescribed for maintaining stable basal insulin levels and improving glycemic control in both type 1 and type 2 diabetes patients. In 2023, the market was...